BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16102592)

  • 1. Biallelic deletion and loss of expression analysis of genes at FRA2G common fragile site in tumor-derived cell lines.
    Limongi ZM; Curatolo A; Pelliccia F; Rocchi A
    Cancer Genet Cytogenet; 2005 Sep; 161(2):181-6. PubMed ID: 16102592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional profiling of genes at the human common fragile site FRA1H in tumor-derived cell lines.
    Pelliccia F; Curatolo A; Limongi ZM; Bosco N; Rocchi A
    Cancer Genet Cytogenet; 2007 Oct; 178(2):144-50. PubMed ID: 17954271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common chromosomal fragile site FRA16D mutation in cancer cells.
    Finnis M; Dayan S; Hobson L; Chenevix-Trench G; Friend K; Ried K; Venter D; Woollatt E; Baker E; Richards RI
    Hum Mol Genet; 2005 May; 14(10):1341-9. PubMed ID: 15814586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common fragile sites, extremely large genes, neural development and cancer.
    Smith DI; Zhu Y; McAvoy S; Kuhn R
    Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal fragile sites FRA3B and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer.
    Sbrana I; Veroni F; Nieri M; Puliti A; Barale R
    Genes Chromosomes Cancer; 2006 May; 45(5):429-36. PubMed ID: 16419058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the common fragile site FRA9E and its potential role in ovarian cancer.
    Callahan G; Denison SR; Phillips LA; Shridhar V; Smith DI
    Oncogene; 2003 Jan; 22(4):590-601. PubMed ID: 12555072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disabled-1 is a large common fragile site gene, inactivated in multiple cancers.
    McAvoy S; Zhu Y; Perez DS; James CD; Smith DI
    Genes Chromosomes Cancer; 2008 Feb; 47(2):165-74. PubMed ID: 18008369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakages at common fragile sites set boundaries of amplified regions in two leukemia cell lines K562 - Molecular characterization of FRA2H and localization of a new CFS FRA2S.
    Pelliccia F; Bosco N; Rocchi A
    Cancer Lett; 2010 Dec; 299(1):37-44. PubMed ID: 20851513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DMD and IL1RAPL1: two large adjacent genes localized within a common fragile site (FRAXC) have reduced expression in cultured brain tumors.
    McAvoy S; Ganapathiraju S; Perez DS; James CD; Smith DI
    Cytogenet Genome Res; 2007; 119(3-4):196-203. PubMed ID: 18253029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RORA, a large common fragile site gene, is involved in cellular stress response.
    Zhu Y; McAvoy S; Kuhn R; Smith DI
    Oncogene; 2006 May; 25(20):2901-8. PubMed ID: 16462772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential loss of expression of common fragile site genes between oral tongue and oropharyngeal squamous cell carcinomas.
    Soderberg C; Perez DS; Ukpo OC; Liang X; O'Reilly AG; Moore EJ; Kademani D; Smith DI
    Cytogenet Genome Res; 2008; 121(3-4):201-10. PubMed ID: 18758160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication timing of two human common fragile sites: FRA1H and FRA2G.
    Pelliccia F; Bosco N; Curatolo A; Rocchi A
    Cytogenet Genome Res; 2008; 121(3-4):196-200. PubMed ID: 18758159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stably transfected common fragile site sequences exhibit instability at ectopic sites.
    Ragland RL; Glynn MW; Arlt MF; Glover TW
    Genes Chromosomes Cancer; 2008 Oct; 47(10):860-72. PubMed ID: 18615677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common fragile site profiling in epithelial and erythroid cells reveals that most recurrent cancer deletions lie in fragile sites hosting large genes.
    Le Tallec B; Millot GA; Blin ME; Brison O; Dutrillaux B; Debatisse M
    Cell Rep; 2013 Aug; 4(3):420-8. PubMed ID: 23911288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common fragile sites.
    Glover TW
    Cancer Lett; 2006 Jan; 232(1):4-12. PubMed ID: 16229941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common chromosomal fragile sites and cancer: focus on FRA16D.
    O'Keefe LV; Richards RI
    Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common fragile genes.
    Matsuyama A; Croce CM; Huebner K
    Eur J Histochem; 2004; 48(1):29-36. PubMed ID: 15145773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-random inactivation of large common fragile site genes in different cancers.
    McAvoy S; Ganapathiraju SC; Ducharme-Smith AL; Pritchett JR; Kosari F; Perez DS; Zhu Y; James CD; Smith DI
    Cytogenet Genome Res; 2007; 118(2-4):260-9. PubMed ID: 18000379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of homozygous deletions in human cancer genomes.
    Cox C; Bignell G; Greenman C; Stabenau A; Warren W; Stephens P; Davies H; Watt S; Teague J; Edkins S; Birney E; Easton DF; Wooster R; Futreal PA; Stratton MR
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4542-7. PubMed ID: 15761058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.